Tag Archives: patients

Regeneron antibody ‘cocktail’ can save lives in hospitalized Covid patients, study finds

LONDON — Another potentially life-saving treatment for hospitalized Covid-19 patients has been discovered by researchers at the University of Oxford. The British study — part of the wider Recovery trial investigating various possible treatments for people hospitalized with coronavirus — found that an antibody combination made by Regeneron reduces the risk of death when given to… Read More »

Covid China: Patients ‘are getting sicker FASTER’ due to Indian variant

Covid patients ‘are getting sicker FASTER’ in China as south of nation battles flare-up fuelled by Indian variant Medics in China say four times as many patients fall severely ill within four days Adds to growing evidence Delta strain more dangerous than previous variants UK experts say younger people also more likely to be admitted… Read More »

Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer® (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult… Read More »

Spending on Medicines In and Post-COVID Say a Lot About Patients and Larger Healthcare Trends – an IQVIA Update

Spending on medicines, globally, will rebound this year and rise above pre-pandemic levels through 2025. Between 2021 and 2025, the annual growth global growth rate for prescription drugs spending is expected to range from 3% to 6%, a $ 1.6 trillion bill for the worlds’s total Rx medicines market. That relatively low single-digit growth rate… Read More »

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today announced that the U.S. Food and Drug Administration (FDA) has approved… Read More »